recent data demonstrated that several ERAD factors ( Fig. 1) , Derlins 10 , UBAC2 (refs. 4,10) and iRhoms 11 are inactive homologs of intramembrane proteases known as rhomboids, which have key roles in controlling epidermal growth factor receptor (EGFR) signaling and in regulating mitochondrial fusion dynamics 12 . These data suggest that common mechanistic features underlie dislocation and rhomboid mediated intramembrane proteo lysis. The aspartyl intramembrane protease signal pep tide peptidase (SPP) has also been suggested to participate in ERAD 13 , but its precise role is unclear, and SPPmediated cleavage outside of signalsequence cleavage sites has yet to be reported for an ERAD substrate. Therefore, questions of whether a protease besides the proteasome is involved in dislocation, whether observed fragments of membrane substrates represent true degradation inter mediates or are simply experimental artifacts and what the exact role of ERlocalized inactive rhomboidprotease homologs is in dislocation remain unanswered.
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In a recent paper 14 , Fleig et al. provide a tantalizing clue to this puzzle by suggesting a proteolytic role for the rhomboid RHBDL4 in the ERAD of unstable membrane proteins. The authors found that RHBDL4 localizes to the ER and is upregulated upon chemical induction of ER stress, which suggests a role for RHBDL4 in maintaining ER homeostasis. Unlike Derlins Membrane proteins represent an especially complex challenge for the dislocation machin ery, as they may contain a combination of luminal and membrane domains. The energy required to extract a membrane domain is likely to largely depend on factors such as the hydro phobicity of the component transmembrane segments and the presence of exoplasmic disul fide bonds. For example, increasing the hydro phobicity of a transmembrane segment of the ERAD substrate cystic fibrosis transmembrane conductance regulator (CFTR) resulted in an increased dependence on p97/VCP for CFTR degradation in a semireconstituted system 5 . In the case of CFTR, dislocation is highly coupled to proteolysis by the proteasome, and CFTR is released from the ER in fragments 6 . In theory, proteolytic cleavages of integral membrane substrates within regions inacces sible to the proteasome-the membrane or ER lumen-could facilitate dislocation by destabi lizing membrane segments and releasing them from luminal domains, thus reducing what is likely a substantial energy barrier.
Although fulllength intermediates of ERAD substrates have been observed in the cytosol, which suggests that the dislocation machinery is able to dislocate entire proteins 3 , fragments of ERAD substrates have been detected with proteasome inhibition [7] [8] [9] , which indicates that another protease may be involved. Intriguingly, Secreted and transmembrane proteins account for approximately onethird of the eukaryotic proteome, and the endoplasmic reticulum (ER) provides a specialized environment for their oxidative folding, modification and oligomer ization. In addition, the ER must constantly combat competing offpathway folding reac tions culminating in nonnative, aggregation prone conformers that can result not only in nonfunctional proteins but also in proteo toxic cell stress. The ER has therefore evolved a robust qualitycontrol system composed of two branches: the unfoldedprotein response (UPR) 1 , which transmits stress signals to the cytosol and nucleus to effect global changes in transcription and translation, and ERAD 2,3 , which targets misfolded secretory proteins for destruction.
The ERAD machinery consists of luminal, integralmembrane and cytosolic factors that are organized around membraneembedded E3 ubiquitin ligases to mediate the recognition, dislocation and ubiquitination of terminally misfolded proteins and their delivery from the ER to cytosolic proteasomes 2, 4 . The underlying mechanism(s) by which ERAD substrates are dislocated into the cytosol remains unknown, but it is clear that in most cases, this process is coupled to the energy derived from ATP hydrolysis by p97/VCP 2,3 , a highly abundant cytosolic AAA ATPase. Many of the proteins involved in ERAD contain p97/VCP-binding sites, perhaps reflecting the need to adapt p97/VCP function toward substratespecific ERAD pathways in order to accommodate the diverse set of proteins degraded by ERAD.
Making the cut: intramembrane cleavage by a rhomboid protease promotes ERAD Ethan J Greenblatt, James A Olzmann & Ron R Kopito Endoplasmic reticulum-associated degradation (ERAD) is a cellular protein quality-control process that disposes of proteasomal substrates from the early secretory pathway. Recent work shows that the endoplasmic reticulumresident rhomboid protease RHBDL4 facilitates ERAD by recognizing and cleaving integral membrane substrates. The work indicates that intramembrane proteolysis may have a general role in the extraction of misfolded membrane proteins from the endoplasmic reticulum. Mutation of the RHBDL4 UIM domain sub stantially reduced cleavage of pTα, which sug gests that the commitment of pTα to RHBDL4 cleavage is mediated at least in part through ubiquitination. Consistent with this hypothesis, overexpression of a dominantnegative version of the E3 ligase gp78 also blocked RHBDL4 dependent cleavage of pTα.
The identification of an interaction between RHBDL4 and p97/VCP suggests a straight forward model of RHBDL4 function in ERAD (Fig. 2a) : membrane ERAD substrates accumulate ubiquitin chains, thereby specify ing RHBDL4 activity toward these proteins. p97/VCP is subsequently recruited directly by RHBDL4 to cytosolically exposed sub strate fragments, which are then dislocated, whereas luminal fragments are presumably disposed of by an alternate pathway. Several other ERAD components contain ubiquitin binding domains, including the rhomboid UBAC2, which is also involved in ERAD and is indirectly coupled to p97/VCP through its interaction with UBXD8 (ref. 4) , which suggests that ubiquitin binding may repre sent a common mechanism for increasing the specificity of the dislocation machinery toward substrates.
Further studies will determine how general RHBDL4 function is in ERAD and the rules for substrate selection by RHBDL4. In the case of pTα but not TCRα, RHBDL4generated frag ments were dislocated and were degraded at a more rapid rate than the fulllength protein.
that is used for substrate recognition by ERAD. By inserting destabilizing positively charged amino acids into the transmembrane regions of the singlepass membrane protein myelin protein zero (MPZ) and the multiplepass membrane proteins opsin and polycystin1, the authors were able to convert these proteins into ERAD substrates as well. RHBDL4 over expression resulted in the accumulation of frag ments of each of these proteins. Interestingly, ectodomain cleavages were observed for pTα as well as for the secreted hormone prolactin fused to the transmembrane and cytosolic domains of pTα, consistent with prior studies showing that the rhomboid cleavage site is accessible from outside of the membrane. In addition, knockdown of RHBDL4 resulted in a stabilization of mutant opsin, which suggests that its dislocation is promoted by endogenous RHBDL4 activity. Together, these data indicate that RHBDL4 is able to cleave topologically diverse membrane substrates, both within and outside of the membrane, consistent with a rather general role in ERAD.
Promiscuous RHBDL4 activity could potentially result in the deleterious cleavage of nascent membrane proteins that have not had the opportunity to fold. Fleig et al. describe an elegant mechanism for specifying RHBDL4 activity toward ERAD substrates. The authors identified a ubiquitinbinding UIM domain in the cytosolic C terminus of RHBDL4 and demonstrated that it is required for the associa tion of RHBDL4 with ubiquitinated proteins. and iRhoms, RHBDL4 has a conserved serine histidine pair homologous to active site resi dues of known rhomboid proteases, consistent with RHBDL4 being a bona fide protease.
To test whether RHBDL4 proteolytic activity is involved in an ERADlike process, the authors examined the effect of coexpressing RHBDL4 with a constitutively degraded orphan α subunit of the pre-Tcell receptor (pTα). The overexpression of wildtype RHBDL4 but not a catalyticsite mutant resulted in the accumu lation of fragments of pTα. These fragments were localized to the cytosol and stabilized by proteasome inhibition, which implies that overexpressed RHBDL4 is capable of cleav ing an ERAD substrate into fragments that are subsequently dislocated and degraded. Knocking down RHBDL4 or overexpressing the dominantnegative mutant resulted in not only impaired pTα degradation but also activa tion of the UPR, which suggests that RHBDL4 activity is required for ERAD of at least some endogenous substrates. These data do not preclude the possibility that RHBDL4 itself functions in the UPR directly or indirectly, for example by regulating anterograde trafficking of ER proteins, as has been demonstrated for iRhom2 (refs. 15,16) .
How general is the function of RHBDL4 in ERAD? Fleig et al. tested whether RHBDL4 is capable of cleaving an assortment of structur ally unrelated ERAD membrane substrates. pTα and an orphan chain of the Tcell receptor, TCRα, each contain basic amino acids, a feature Figure 2 Roles for the rhomboid family in ERAD. (a) Model of the RHBDL4 ERAD pathway. RHBDL4 recognizes integral membrane substrates bearing transmembrane helices destabilized by an exposed positively charged residue(s) (red + symbols). Ubiquitination by an upstream E3 ligase provides a critical signal that is recognized by the RHBDL4 UIM and commits the substrate for RHBDL4-mediated proteolytic cleavage. The resulting substrate fragments are subsequently dislocated in a p97/VCP-dependent manner and targeted to the proteasome for degradation. (b) Model of a potential mechanism for inactive rhomboids in ERAD. Inactive rhomboids may function in the recognition and recruitment of misfolded substrates (red * symbols) to dislocation complexes. Structural features within inactive rhomboids 22 may catalyze p97/VCP-dependent substrate dislocation by destabilizing substrates through a combination of α-helical transmembrane-domain unwinding and local membrane thinning. 
